Format

Send to

Choose Destination
See comment in PubMed Commons below
South Med J. 2008 Jan;101(1):63-9. doi: 10.1097/SMJ.0b013e31815d4398.

Myasthenia gravis crisis.

Author information

1
Division of Neurocritical Care, The Neurological Institute, University Hospitals Case Medical Center, Department of Neurology, Case Western Reserve University, Cleveland, Ohio, USA.

Abstract

Myasthenia gravis (MG) is an autoimmune disorder resulting from the production of antibodies against acetylcholine receptors leading to the destruction of the postsynaptic membrane at the neuromuscular junction. In the US there are about 18,000 people with MG. Myasthenia gravis crisis (MGC) is defined as any MG exacerbation necessitating mechanical ventilation. Most patients presenting with MGC have an identifiable risk factor. The diagnosis of MGC should be suspected in all patients with respiratory failure, particularly those with unclear etiology. Acute management of MGC requires supportive general and ventilatory therapy and institution of measures to improve the neuromuscular blockade. The latter includes plasma exchange or i.v. immunoglobulin, and removal of the offending trigger. The outcome of patients with MGC has improved significantly and the current mortality rate is about 4 to 8%.

PMID:
18176295
DOI:
10.1097/SMJ.0b013e31815d4398
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Southern Medical Association
    Loading ...
    Support Center